BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28329340)

  • 1. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study.
    McNeil JJ; Woods RL; Nelson MR; Murray AM; Reid CM; Kirpach B; Storey E; Shah RC; Wolfe RS; Tonkin AM; Newman AB; Williamson JD; Lockery JE; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Trevaks RE; Orchard SG; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Grimm RH;
    J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1586-1593. PubMed ID: 28329340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
    ASPREE Investigator Group
    Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudy.
    Barker AL; McNeil JJ; Seeman E; Ward SA; Sanders KM; Khosla S; Cumming RG; Pasco JA; Bohensky MA; Ebeling PR; Woods RL; Lockery JE; Wolfe R; Talevski J;
    Inj Prev; 2016 Aug; 22(4):297-301. PubMed ID: 26002770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
    McNeil JJ; Woods RL; Nelson MR; Reid CM; Kirpach B; Wolfe R; Storey E; Shah RC; Lockery JE; Tonkin AM; Newman AB; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Ryan J; Radziszewska B; Grimm R; Murray AM;
    N Engl J Med; 2018 Oct; 379(16):1499-1508. PubMed ID: 30221596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults.
    Woods RL; Espinoza S; Thao LTP; Ernst ME; Ryan J; Wolfe R; Shah RC; Ward SA; Storey E; Nelson MR; Reid CM; Lockery JE; Orchard SG; Trevaks RE; Fitzgerald SM; Stocks NP; Williamson JD; McNeil JJ; Murray AM; Newman AB
    J Gerontol A Biol Sci Med Sci; 2021 Oct; 76(11):2007-2014. PubMed ID: 33367621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial.
    Lockery JE; Ernst ME; Broder JC; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Reid CM; Liew D; Woods RL;
    Pharmacotherapy; 2020 Oct; 40(10):1042-1053. PubMed ID: 33078479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
    Ryan J; Storey E; Murray AM; Woods RL; Wolfe R; Reid CM; Nelson MR; Chong TTJ; Williamson JD; Ward SA; Lockery JE; Orchard SG; Trevaks R; Kirpach B; Newman AB; Ernst ME; McNeil JJ; Shah RC;
    Neurology; 2020 Jul; 95(3):e320-e331. PubMed ID: 32213642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease.
    Wolfe R; Wetmore JB; Woods RL; McNeil JJ; Gallagher H; Roderick P; Walker R; Nelson MR; Reid CM; Shah RC; Ernst ME; Lockery JE; Tonkin AM; Abhayaratna WP; Gibbs P; Wood EM; Mahady SE; Williamson JD; Donnan GA; Cloud GC; Murray AM; Polkinghorne KR
    Kidney Int; 2021 Feb; 99(2):466-474. PubMed ID: 32920022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults.
    Zhou Z; Ofori-Asenso R; Curtis AJ; Breslin M; Wolfe R; McNeil JJ; Murray AM; Ernst ME; Reid CM; Lockery JE; Woods RL; Tonkin AM; Nelson MR
    J Am Coll Cardiol; 2020 Jul; 76(1):17-27. PubMed ID: 32616158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
    Broder JC; Ryan J; Shah RC; Lockery JE; Orchard SG; Gilmartin-Thomas JF; Fravel MA; Owen AJ; Woods RL; Wolfe R; Storey E; Murray AM; Ernst ME
    Pharmacotherapy; 2022 Feb; 42(2):134-144. PubMed ID: 34866212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    McNeil JJ; Wolfe R; Woods RL; Tonkin AM; Donnan GA; Nelson MR; Reid CM; Lockery JE; Kirpach B; Storey E; Shah RC; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Johnston CI; Ryan J; Radziszewska B; Jelinek M; Malik M; Eaton CB; Brauer D; Cloud G; Wood EM; Mahady SE; Satterfield S; Grimm R; Murray AM;
    N Engl J Med; 2018 Oct; 379(16):1509-1518. PubMed ID: 30221597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
    Jordan F; Quinn TJ; McGuinness B; Passmore P; Kelly JP; Tudur Smith C; Murphy K; Devane D
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011459. PubMed ID: 32352165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar mortality risk in incident cognitive impairment and dementia: Evidence from the ASPirin in Reducing Events in the Elderly (ASPREE) trial.
    Lin X; Banaszak-Holl J; Xie J; Ward SA; Brodaty H; Storey E; Shah RC; Murray A; Ryan J; Orchard SG; Fitzgerald SM; McNeil JJ
    J Am Geriatr Soc; 2021 Dec; 69(12):3568-3575. PubMed ID: 34533211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly - eXTension (ASPREE-XT) Observational Study.
    Ernst ME; Broder JC; Wolfe R; Woods RL; Nelson MR; Ryan J; Shah RC; Orchard SG; Chan AT; Espinoza SE; Wilson M; Kirpach B; Reid CM; McNeil JJ; Williamson JD; Murray AM;
    Contemp Clin Trials; 2023 Jul; 130():107231. PubMed ID: 37196887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial.
    Barker AL; Morello R; Thao LTP; Seeman E; Ward SA; Sanders KM; Cumming RG; Pasco JA; Ebeling PR; Woods RL; Wolfe R; Khosla S; Hussain SM; Ronaldson K; Newman AB; Williamson JD; McNeil JJ
    JAMA Intern Med; 2022 Dec; 182(12):1289-1297. PubMed ID: 36342703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
    Nelson MR; Reid CM; Ames DA; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Krum H; Storey E; Tonkin A; Wolfe R; Woods R; McNeil JJ
    Med J Aust; 2008 Jul; 189(2):105-9. PubMed ID: 18637782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial.
    Zoungas S; Zhou Z; Owen AJ; Curtis AJ; Espinoza SE; Ernst ME; Woods RL; Orchard SG; McNeil JJ; Murray AM; Nelson MR; Reid CM; Ryan J; Wolfe R
    Lancet Diabetes Endocrinol; 2024 Feb; 12(2):98-106. PubMed ID: 38142708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study.
    Espinoza SE; Woods RL; Ekram ARMS; Ernst ME; Polekhina G; Wolfe R; Shah RC; Ward SA; Storey E; Nelson MR; Reid CM; Lockery JE; Orchard SG; Trevaks R; Fitzgerald SM; Stocks NP; Chan A; McNeil JJ; Murray AM; Newman AB; Ryan J
    J Gerontol A Biol Sci Med Sci; 2022 Oct; 77(10):2007-2014. PubMed ID: 34758073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial.
    Berk M; Woods RL; Nelson MR; Shah RC; Reid CM; Storey E; Fitzgerald S; Lockery JE; Wolfe R; Mohebbi M; Dodd S; Murray AM; Stocks N; Fitzgerald PB; Mazza C; Agustini B; McNeil JJ
    JAMA Psychiatry; 2020 Oct; 77(10):1012-1020. PubMed ID: 32492080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).
    Nelson M; Reid C; Beilin L; Donnan G; Johnston C; Krum H; Storey E; Tonkin A; McNeil J;
    Drugs Aging; 2003; 20(12):897-903. PubMed ID: 14565783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.